Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2345 - A Prospective, Phase II, Single-Arm Trial Evaluating Efficacy and Safety of the Regimen of Induction Cadonilimab plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Cadonilimab Therapy for Unresectable Stage III NSCLC
Speaker: CHU, Li - FUDAN UNIVERSITY SHANGHAI CANCER CENTER, SHANGHAI
4:45 PM - 6:00 PM PT

2346 - Toxicities of Brain and Spinal Cord Photon and Proton Radiation in Pediatric Brain Tumors Assessed by Real-World Data (RWD)
Speaker: Craig, Brandon, MD, PhD - University of Calgary, Calgary, AB
4:45 PM - 6:00 PM PT

2347 - STEREOTACTIC BODY RADIOTHERAPY FOR THE TREATMENT OF OLIGOMETASTASES LOCATED IN THE PERITONEUM OR IN THE ABDOMINAL WALL: PRELIMINARY RESULTS FROM A MONO-INSTITUTIONAL ANALYSIS
Speaker: Cuccia, Francesco, MD - ARNAS - Civico Hospital, Palermo, PA
4:45 PM - 6:00 PM PT

2348 - Biology-Guided Radiotherapy for Lung and Bone Tumors: Early Insights into Local Control Outcomes from the Prospective Premier Registry
Speaker: Dan, Tu, MD - Thomas Jefferson University, Philadelphia, PA
4:45 PM - 6:00 PM PT

2349 - Representativeness and Generalizability of NCI-Funded Multi-Modality Randomized Clinical Trials (RCTs): A Case Study of Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Based on RTOG-0617 and the National Cancer Database (NCDB)
Speaker: de Sousa, Cecilia, MD, MPH - Johns Hopkins Medicine, Baltimore, MD
4:45 PM - 6:00 PM PT

2350 - Treatment Approach in Childhood Ewing Sarcoma - TROD Hematology Oncology Pediatric Oncology Total Body Irradiation Working Group Survey Study
Speaker: Demiroz, Candan, MD, RT - Uludag University Faculty of Medicine, Bursa
4:45 PM - 6:00 PM PT

2351 - Efficacy and Safety of Oral Chemotherapy Concurrent Radiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer after Neoadjuvant Chemoimmunotherapy
Speaker: Deng, Lei - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing, Beijing
4:45 PM - 6:00 PM PT

2352 - Evaluation of Factors Affecting Radiological Changes and Treatment Response Following LUNG Stereotactic Ablative Radiotherapy
Speaker: Dincbas, Fazilet, MD - Memorial Hospital, Chattanooga, TN
4:45 PM - 6:00 PM PT

2353 - Dosimetric Evaluation of Radiotherapy Planning Optimization Based on Cardiac Subvolumes in Patients with Lung Cancer
Speaker: Dincbas, H. Fazilet, MD - Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul, Istanbul
4:45 PM - 6:00 PM PT

2354 - MTA3-Driven Glutamine Synthetase Upregulation as a Mechanism for Radiosensitivity Regulation in Non-Small Cell Lung Cancer
Speaker: Du, Liang, PhD - Chongqing University Cancer Hospital, Chongqing, Chongqing
4:45 PM - 6:00 PM PT

2355 - Functional Outcome Evaluation of Gamma Knife Stereotactic Radiosurgery Treatment for Essential and Parkinsonian Tremor - A Private Institution Evaluation
Speaker: Dunham, Daniele, ROCN - South Sound Gamma Knife, Tacoma, WA
4:45 PM - 6:00 PM PT

2356 - Contemporary Experience with Percutaneous High Dose Rate (HDR) Brachyablation for Malignant Lung Tumors
Speaker: Eala, Michelle Ann, MD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles, CA